Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Alternative redox forms of ASNA-1 separate insulin signaling from tail-anchored protein targeting and cisplatin resistance in C. elegans
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Surgery.ORCID iD: 0000-0001-5824-6263
Show others and affiliations
2021 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 11, no 1, article id 8678Article in journal (Refereed) Published
Abstract [en]

Cisplatin is a frontline cancer therapeutic, but intrinsic or acquired resistance is common. We previously showed that cisplatin sensitivity can be achieved by inactivation of ASNA-1/TRC40 in mammalian cancer cells and in Caenorhabditis elegans. ASNA-1 has two more conserved functions: in promoting tail-anchored protein (TAP) targeting to the endoplasmic reticulum membrane and in promoting insulin secretion. However, the relation between its different functions has remained unknown. Here, we show that ASNA-1 exists in two redox states that promote TAP-targeting and insulin secretion separately. The reduced state is the one required for cisplatin resistance: an ASNA-1 point mutant, in which the protein preferentially was found in the oxidized state, was sensitive to cisplatin and defective for TAP targeting but had no insulin secretion defect. The same was true for mutants in wrb-1, which we identify as the C. elegans homolog of WRB, the ASNA1/TRC40 receptor. Finally, we uncover a previously unknown action of cisplatin induced reactive oxygen species: cisplatin induced ROS drives ASNA-1 into the oxidized form, and selectively prevents an ASNA-1-dependent TAP substrate from reaching the endoplasmic reticulum. Our work suggests that ASNA-1 acts as a redox-sensitive target for cisplatin cytotoxicity and that cisplatin resistance is likely mediated by ASNA-1-dependent TAP substrates. Treatments that promote an oxidizing tumor environment should be explored as possible means to combat cisplatin resistance.

Place, publisher, year, edition, pages
Springer, 2021. Vol. 11, no 1, article id 8678
National Category
Surgery
Identifiers
URN: urn:nbn:se:umu:diva-182496DOI: 10.1038/s41598-021-88085-yISI: 000644202000020PubMedID: 33883621Scopus ID: 2-s2.0-85104701525OAI: oai:DiVA.org:umu-182496DiVA, id: diva2:1546741
Available from: 2021-04-23 Created: 2021-04-23 Last updated: 2023-09-05Bibliographically approved

Open Access in DiVA

fulltext(6761 kB)165 downloads
File information
File name FULLTEXT01.pdfFile size 6761 kBChecksum SHA-512
7321d031a61f7557d50f2da5c4cd8e21a116922dd6c1cc193ac0bf7ecf86e5e16b31cac7f11ad96511dbc774592e56d48f13619a709ccd3df0bf9720cdd165c0
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Billing, OlaHemmingsson, Oskar

Search in DiVA

By author/editor
Billing, OlaHemmingsson, Oskar
By organisation
Surgery
In the same journal
Scientific Reports
Surgery

Search outside of DiVA

GoogleGoogle Scholar
Total: 165 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 274 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf